Stock Analysts

NPS Pharmaceuticals’ Natpara Approved with Boxed Warning

Updates on the regulatory front are eagerly awaited by investors in the pharma/biotech sector as they impact the share price of the concerned company. Regulatory updates include events like filing of investigational new drug applications and marketing applications, acceptance of these applications for review by regulatory agencies, reviews by advisory panels and, finally, a response from the regulatory agency regarding the approval status. Late last week, good news came NPS Pharmaceuticals, Inc […]

Stock Analysts

Will Nasdaq (NDAQ) Surprise This Earnings Season?

Leading exchange operator – Nasdaq Group Inc. ( NDAQ ) is scheduled to release third-quarter 2014 financial results before the opening bell on Jan 28, 2015. In the last reported quarter, the company delivered a positive earnings surprise of 2.9%, while it kept the earnings streak alive with the four-quarter trailing average beat of 2.9% […]

Stock Analysts

Can Meredith (MDP) Keep Its Earnings Streak Alive in Q2?

Meredith Corporation ( MDP ), one of the leading media and marketing companies with interests in publishing, broadcasting, integrated marketing and interactive media, is slated to report its second-quarter fiscal 2015 results on Jan 28. In the last quarter, it posted a positive surprise of 3.2%. Let’s see how things are shaping up prior to this announcement […]